Verus Capital Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$409K Buy
1,161
+17
+1% +$6.06K 0.03% 307
2025
Q4
$375K Sell
1,144
-8
-0.7% -$2.54K 0.02% 315
2025
Q3
$325K Sell
1,152
-179
-13% -$51.9K 0.03% 309
2025
Q2
$372K Sell
1,331
-16
-1% -$4.53K 0.03% 260
2025
Q1
$420K Sell
1,347
-699
-34% -$206K 0.04% 228
2024
Q4
$533K Sell
2,046
-266
-12% -$78.9K 0.05% 191
2024
Q3
$746K Sell
2,312
-42
-2% -$13.7K 0.07% 154
2024
Q2
$736K Buy
2,354
+130
+6% +$38.2K 0.08% 148
2024
Q1
$632K Buy
2,224
+66
+3% +$19.3K 0.07% 159
2023
Q4
$622K Buy
2,158
+58
+3% +$15.8K 0.08% 146
2023
Q3
$564K Sell
2,100
-20
-0.9% -$4.99K 0.08% 145
2023
Q2
$471K Buy
2,120
+36
+2% +$8.35K 0.07% 168
2023
Q1
$504K Sell
2,084
-15
-0.7% -$3.68K 0.08% 153
2022
Q4
$551K Buy
2,099
+58
+3% +$15.5K 0.1% 136
2022
Q3
$460K Sell
2,041
-31
-1% -$7.51K 0.09% 153
2022
Q2
$504K Sell
2,072
-72
-3% -$17.6K 0.1% 145
2022
Q1
$512K Buy
+2,144
New +$493K 0.08% 170
2020
Q1
$262K Buy
1,292
+50
+4% +$10.9K 0.08% 149
2019
Q4
$299K Buy
+1,242
New +$274K 0.1% 162

Other funds holding AMGN

Verus Capital Partners's AMGN Position: Q1 2026 in Review

Verus Capital Partners increased its Amgen (AMGN) stake by 1.5% in Q1 2026, buying an estimated $6.06K and bringing the position to 1,161 shares worth $409K. The position accounts for 0.03% of the portfolio, ranked #307.

Verus Capital Partners first reported a position in AMGN in Q4 2019 and has held it in 19 quarters since. The position peaked at $746K in Q3 2024. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Verus Capital Partners held 1,161 shares of Amgen worth $409K as of Q1 2026.
  • Verus Capital Partners bought 17 Amgen shares in Q1 2026, an estimated $6.06K.
  • Amgen made up 0.03% of Verus Capital Partners's portfolio in Q1 2026, its #307 holding.
  • Verus Capital Partners first reported a position in Amgen in Q4 2019 and has held it in 19 quarters since.
  • Verus Capital Partners's Amgen position peaked at $746K in Q3 2024.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Verus Capital Partners's 13F filing for Q1 2026, filed 22 May 2026.